Literature DB >> 20878418

Anti-NMDA receptor encephalitis after TdaP-IPV booster vaccination: cause or coincidence?

Caroline Hofmann, Marc-Oliver Baur, Horst Schroten.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20878418     DOI: 10.1007/s00415-010-5757-3

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  5 in total

1.  Anti-NMDA-receptor encephalitis: a cause of psychiatric, seizure, and movement disorders in young adults.

Authors:  Angela Vincent; Christian G Bien
Journal:  Lancet Neurol       Date:  2008-10-11       Impact factor: 44.182

2.  Post-marketing safety evaluation of a tetanus toxoid, reduced diphtheria toxoid and 3-component acellular pertussis vaccine administered to a cohort of adolescents in a United States health maintenance organization.

Authors:  Nicola P Klein; John Hansen; Edwin Lewis; Liisa Lyon; Bessie Nguyen; Steven Black; Wayde M Weston; Sterling Wu; Ping Li; Barbara Howe; Leonard R Friedland
Journal:  Pediatr Infect Dis J       Date:  2010-07       Impact factor: 2.129

3.  Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies.

Authors:  Josep Dalmau; Amy J Gleichman; Ethan G Hughes; Jeffrey E Rossi; Xiaoyu Peng; Meizan Lai; Scott K Dessain; Myrna R Rosenfeld; Rita Balice-Gordon; David R Lynch
Journal:  Lancet Neurol       Date:  2008-10-11       Impact factor: 44.182

Review 4.  Influenza and autoimmunity.

Authors:  Natasa Toplak; Tadej Avcin
Journal:  Ann N Y Acad Sci       Date:  2009-09       Impact factor: 5.691

5.  Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents.

Authors:  Nicole R Florance; Rebecca L Davis; Christopher Lam; Christina Szperka; Lei Zhou; Saba Ahmad; Cynthia J Campen; Heather Moss; Nadja Peter; Amy J Gleichman; Carol A Glaser; David R Lynch; Myrna R Rosenfeld; Josep Dalmau
Journal:  Ann Neurol       Date:  2009-07       Impact factor: 10.422

  5 in total
  11 in total

1.  Postural tachycardia syndrome (POTS) with anti-NMDA receptor antibodies after human papillomavirus vaccination.

Authors:  Svetlana Blitshteyn; Jill Brook
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

Review 2.  Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis.

Authors:  Josep Dalmau; Eric Lancaster; Eugenia Martinez-Hernandez; Myrna R Rosenfeld; Rita Balice-Gordon
Journal:  Lancet Neurol       Date:  2011-01       Impact factor: 44.182

Review 3.  Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.

Authors:  Mia Levite
Journal:  J Neural Transm (Vienna)       Date:  2014-08-01       Impact factor: 3.575

Review 4.  Neurologic Safety Monitoring of COVID-19 Vaccines: Lessons From the Past to Inform the Present.

Authors:  Kiran Teresa Thakur; Samantha Epstein; Amanda Bilski; Alanna Balbi; Amelia K Boehme; Thomas H Brannagan; Sarah Flanagan Wesley; Claire S Riley
Journal:  Neurology       Date:  2021-09-02       Impact factor: 9.910

5.  Anti-NMDA Receptor Encephalitis and Vaccination.

Authors:  Hsiuying Wang
Journal:  Int J Mol Sci       Date:  2017-01-18       Impact factor: 5.923

6.  Prodromal headache in anti-NMDAR encephalitis: An epiphenomenon of NMDAR autoimmunity.

Authors:  Naomi Tominaga; Naomi Kanazawa; Atsushi Kaneko; Juntaro Kaneko; Eiji Kitamura; Hiroto Nakagawa; Kazutoshi Nishiyama; Takahiro Iizuka
Journal:  Brain Behav       Date:  2018-06-01       Impact factor: 2.708

7.  Emerging role of prodromal headache in patients with anti-N-methyl-D-aspartate receptor encephalitis.

Authors:  Congcong Ma; Chengze Wang; Qiaoman Zhang; Yajun Lian
Journal:  J Pain Res       Date:  2019-01-30       Impact factor: 3.133

8.  Phylogenetic Analysis to Explore the Association Between Anti-NMDA Receptor Encephalitis and Tumors Based on microRNA Biomarkers.

Authors:  Hsiuying Wang
Journal:  Biomolecules       Date:  2019-10-05

9.  Detection of anti-NMDA receptor antibodies following BBIBP-CorV COVID-19 vaccination in a rituximab-treated person with multiple sclerosis presenting with manifestations of an acute relapse.

Authors:  Masoud Etemadifar; Hosein Nouri; Mehri Salari; Nahad Sedaghat
Journal:  Hum Vaccin Immunother       Date:  2022-03-03       Impact factor: 3.452

10.  Psychiatric Presentation of Anti-NMDA Receptor Encephalitis.

Authors:  Dominique Endres; Sebastian Rauer; Winfried Kern; Nils Venhoff; Simon J Maier; Kimon Runge; Patrick Süß; Bernd Feige; Kathrin Nickel; Timo Heidt; Katharina Domschke; Karl Egger; Harald Prüss; Philipp T Meyer; Ludger Tebartz van Elst
Journal:  Front Neurol       Date:  2019-11-05       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.